Notably, tumor cells evade immune surveillance by down-regulating NK cells’ sensitivity and upregulating human leukocyte antigen C(HLA-C) and human leukocyte antigen E (HLA-E) expression (69, 72, 76, 77). This evidence concerns the gene HLA-C and neoplasm.